Greater Cannabis Company (GCAN) Amortizatization of Intangibles (2017 - 2022)

Greater Cannabis Company's (GCAN) quarterly Amortizatization of Intangibles came in at $98342.0 in Q1 2022, up 714.22% year-on-year from $12078.0 in Q1 2021, and up 39.81% quarter-over-quarter from $70339.0 in Q4 2021.

Greater Cannabis Company (GCAN) Amortizatization of Intangibles (2017 - 2022) Analysis & Trends

Greater Cannabis Company's Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $98342.0 for Q1 2022.

  • On a quarterly basis, Amortizatization of Intangibles rose 714.22% year-over-year to $98342.0 in Q1 2022; TTM through Dec 2022 was $98342.0, a 63.42% decrease from a year earlier, with the FY2022 full-year figure at $98342.0, down 63.42% from the prior year.
  • Amortizatization of Intangibles rose to $98342.0 in Q1 2022 per GCAN's latest filing, from $70339.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $394800.0 in Q2 2020 and bottomed at $4986.0 in Q4 2018.
  • The 5-year median for Amortizatization of Intangibles is $68691.0 (2021), against an average of $112640.6.
  • Across the five-year window, Amortizatization of Intangibles soared 5764.52% in 2019 and slumped 95.93% in 2021, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $4986.0 in 2018, then surged by 5764.52% to $292405.0 in 2019, then slumped by 50.26% to $145450.0 in 2020, then plunged by 51.64% to $70339.0 in 2021, then surged by 39.81% to $98342.0 in 2022.
  • Per Business Quant, the three latest GCAN Amortizatization of Intangibles figures stand at $98342.0 (Q1 2022), $70339.0 (Q4 2021), and $117746.0 (Q3 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 1.30 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Greater Cannabis Company 236,233.75 234,794.75 - -

Historic Data

Download Data
DateValue
Mar 31, 2022 98,342.00
Mar 31, 2022 98,342.00
Dec 31, 2021 70,339.00
Dec 31, 2021 70,339.00
Sep 30, 2021 117,746.00
Sep 30, 2021 117,746.00
Jun 30, 2021 68,691.00
Jun 30, 2021 68,691.00
Mar 31, 2021 12,078.00
Mar 31, 2021 12,078.00
Dec 31, 2020 145,450.00
Dec 31, 2020 145,450.00
Sep 30, 2020 178,280.00
Sep 30, 2020 178,280.00
Jun 30, 2020 394,800.00
Jun 30, 2020 394,800.00
Mar 31, 2020 297,073.00
Mar 31, 2020 297,073.00
Dec 31, 2019 292,405.00
Dec 31, 2019 292,405.00